Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell S Cairo

Showing results (201-210 of 268) with videos related to

Pageof 27
Sort By:
The Journal of Pediatrics|July 8, 2015
Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis BullosaMark B Geyer, Kavita Radhakrishnan, Roger Giller, et al.
British Journal of Haematology|August 19, 2011
A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipientsMark B Geyer, Judith S Jacobson, Jason Freedman, et al.
Frontiers in Neurology|June 6, 2024
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trialSuzanne Braniecki, Elliott Vichinsky, Mark C Walters, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipientsElif Unal, Catherine Yen, Lisa Saiman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantationCelso A Rodrigues, Guillermo Sanz, Claudio G Brunstein, et al.
Frontiers in Immunology|December 26, 2022
Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell diseaseYaya Chu, Julie-An Talano, Lee Ann Baxter-Lowe, et al.
Frontiers in Immunology|July 24, 2024
Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumorsSiddhi N Paudel, Brian J Hutzen, Katherine E Miller, et al.
Frontiers in Immunology|July 24, 2024
Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumorsSiddhi N Paudel, Brian J Hutzen, Katherine E Miller, et al.
British Journal of Haematology|February 18, 2003
Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experienceMitchell S Cairo, Richard Sposto, Sherrie L Perkins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committeeMichael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Pageof 27

Showing results (201-210 of 268) with videos related to

Sort By:
Pageof 27
The Journal of Pediatrics|July 8, 2015
Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis BullosaMark B Geyer, Kavita Radhakrishnan, Roger Giller, et al.
British Journal of Haematology|August 19, 2011
A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipientsMark B Geyer, Judith S Jacobson, Jason Freedman, et al.
Frontiers in Neurology|June 6, 2024
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trialSuzanne Braniecki, Elliott Vichinsky, Mark C Walters, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipientsElif Unal, Catherine Yen, Lisa Saiman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantationCelso A Rodrigues, Guillermo Sanz, Claudio G Brunstein, et al.
Frontiers in Immunology|December 26, 2022
Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell diseaseYaya Chu, Julie-An Talano, Lee Ann Baxter-Lowe, et al.
Frontiers in Immunology|July 24, 2024
Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumorsSiddhi N Paudel, Brian J Hutzen, Katherine E Miller, et al.
Frontiers in Immunology|July 24, 2024
Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumorsSiddhi N Paudel, Brian J Hutzen, Katherine E Miller, et al.
British Journal of Haematology|February 18, 2003
Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experienceMitchell S Cairo, Richard Sposto, Sherrie L Perkins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committeeMichael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Pageof 27